Title : Long-term sustainability of glycaemic achievements with second-line antidiabetic therapies in patients with type 2 diabetes: A real-world study.

Pub. Date : 2018 Jul

PMID : 29536608






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MATERIALS AND METHODS: From US Centricity Electronic Medical Records, 163 081 patients with type 2 diabetes aged 18 to 80 years, who had initiated metformin, intensified their treatment with dipeptidyl peptidase-4 (DPP-4) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), sulphonylureas (SUs), insulin or thiazolidinediones (TZDs), and continued second-line treatment for >=6 months, were selected. Metformin dipeptidyl peptidase 4 Homo sapiens